Profound Medical Corp (PROF) is now in the Undervalued zone, suggesting that its current forward PS ratio of 7.08 is considered Undervalued compared with the five-year average of -7.77. The fair price of Profound Medical Corp (PROF) is between 7.75 to 21.55 according to relative valuation method. Compared to the current price of 7.46 USD , Profound Medical Corp By Undervalued By 3.77%.

Relative Value

Fair Zone

7.75-21.55

Current Price：7.46

3.77%

Undervalued

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

Unlock 5-Year Valuation Change

Is Profound Medical Corp (PROF) at a historical peak or a rare bargain? Access the full 5-year trend to find out.

Unlock Now

Profound Medical Corp (PROF) has a current Price-to-Book (P/B) ratio of 7.20. Compared to its 3-year average P/B ratio of 4.93, the current P/B ratio is approximately 45.94% higher. Relative to its 5-year average P/B ratio of 4.13, the current P/B ratio is about 74.43% higher. Profound Medical Corp (PROF) has a Forward Free Cash Flow (FCF) yield of approximately -16.18%. Compared to its 3-year average FCF yield of -13.37%, the current FCF yield is approximately 21.02% lower. Relative to its 5-year average FCF yield of -12.94%, the current FCF yield is about 25.01% lower.

Competitors Valuation Multiple

AI Analysis

The average P/S ratio for PROF competitors is 4.49, providing a benchmark for relative valuation. Profound Medical Corp Corp (PROF.O) exhibits a P/S ratio of 7.08, which is 57.79% above the industry average. Given its robust revenue growth of 86.76%, this premium appears sustainable.

P/E

P/S

EV/EBITDA

EV/EBIT

Earnings Growth

Market Cap

Performance Decomposition

AI Analysis

Market capitalization of PROF increased by 0.00% over the past 1 year(s). The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00% to the performance.

Overall, the performance of PROF in the past 1 year(s) is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is PROF currently overvalued or undervalued?

What is Profound Medical Corp (PROF) fair value?

PROF's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. The fair price of Profound Medical Corp (PROF) is between 7.75 to 21.55 according to relative valuation method.

How does PROF's valuation metrics compare to the industry average?

The average P/S ratio for PROF's competitors is 4.49, providing a benchmark for relative valuation. Profound Medical Corp Corp (PROF) exhibits a P/S ratio of 7.08, which is 57.79% above the industry average. Given its robust revenue growth of 86.76%, this premium appears sustainable.

What is the current P/B ratio for Profound Medical Corp (PROF) as of Mar 02 2026?

As of Mar 02 2026, Profound Medical Corp (PROF) has a P/B ratio of 7.20. This indicates that the market values PROF at 7.20 times its book value.

What is the current FCF Yield for Profound Medical Corp (PROF) as of Mar 02 2026?

As of Mar 02 2026, Profound Medical Corp (PROF) has a FCF Yield of -16.18%. This means that for every dollar of Profound Medical Corp's market capitalization, the company generates -16.18 cents in free cash flow.

What is the current Forward P/E ratio for Profound Medical Corp (PROF) as of Mar 02 2026?

As of Mar 02 2026, Profound Medical Corp (PROF) has a Forward P/E ratio of -7.41. This means the market is willing to pay $-7.41 for every dollar of Profound Medical Corp's expected earnings over the next 12 months.

What is the current Forward P/S ratio for Profound Medical Corp (PROF) as of Mar 02 2026?

As of Mar 02 2026, Profound Medical Corp (PROF) has a Forward P/S ratio of 7.08. This means the market is valuing PROF at $7.08 for every dollar of expected revenue over the next 12 months.

PROF Valuation